Back to search

University of Crete (UOC)

Βιταμίνη D και ευπάθεια στη νόσο COVID – 19 σε παιδιά

Abstract

dc:description

Background: Vitamin D is a potent regulator of the innate and acquired immunity responses, with a strong effect on gene expression. Poor vitamin D status has been linked to both greater susceptibility and severity of respiratory infections. The biological actions of vitamin D are executed through the receptor of vitamin D (VDR) and vitamin Dbinding protein (VDBP), to which 25-hydroxyvitamin D (25[OH]D), the major circulating form of vitamin D, is bound. In fact, the major single nucleotide polymorphisms (SNPs) of the VDR gene, the Gc gene encoding the VDBP, and the 1 α-hydroxylase enzyme (CYP27B1) required to convert the circulating 25[OH]D to the active form of 1,25-dihydroxyvitamin D (1,25[OH]2D), have been linked to children’s susceptibility to acute, mainly viral, lower respiratory tract infections. Thus, evidence suggests the possible role of vitamin D as well as its induced antimicrobial peptide LL-37, as an immune modulator. However, the effect of the genetic background mediating vitamin D biological actions on COVID-19 disease in children remains ambiguous. Aim: The hypothesis we aimed to explore is that the vitamin D-related genetic background defining 25(OH)D status may be associated with the occurrence and severity of COVID-19 infection in children. Herein, we explored key genetic variants within the vitamin D pathway in pediatric COVID-19 patients, and in relation to the circulating vitamin D binding protein (VDBP), as well as the role of the cathelicidin antimicrobial peptide in the infection. Methods: In this prospective case - control study, 60 children 0–14 years with SARS-CoV-2 infection and matched controls were genotyped for the VDR gene (FokI, BsmI, TaqI, ApaI), the Gc gene of VDBP (rs7041, rs4588), and the CYP27B1 promoter (rs10877012) single-nucleotide polymorphisms, by polymerase chain reaction and restriction fragment length polymorphism assay. Serum VDBP and the cathelicidin-derived antimicrobial peptide LL-37 concentration was evaluated using enzyme-linked immunosorbent assay technique (ELISA). Results: The FokI FF genotype was more frequent among COVID-19 patients compared to the control group, in which the TaqI TT genotype was prevalent (OR=2.26; 95% CI: 1.08-4.73; p=0.02 and OR=0.29; 95% CI: 0.13-0.63; p=0.001, respectively). The VDR FokI F allele was associated with a 2.04-fold increased risk of COVID-19 (OR=2.04; 95% CI: 1.14–3.64; p=0.01). Gc1F haplotype was significantly more represented in controls compared to COVID-19 patients (OR= 0.39; 95% CI: 0.19-0.81; p=0.01). Multivariable analysis demonstrated an independent association of the VDR FokI F allele with both susceptibility to COVID-19 (adjusted OR=1.91; 95% CI: 1.01–3.59; p=0.044) and disease severity (adjusted OR=3.31; 95% CI: 1.03–10.71; p=0.045), after adjustment for age, sex, and the presence of comorbidities. No significant differences were observed for BsmI, ApaI and Gc rs4588 genotypes between COVID-19 cases and controls. Serum VDBP and LL-37 levels were found similar between both groups. Conclusions: Genotypic distribution in VDR, VDBP and CYP27B1-1260 genes are possibly related to COVID-19 infection and may have a significant clinical impact on disease in children. Τhe F allele of the VDR FokI polymorphism may be independently associated with both susceptibility to COVID-19 and disease severity in children. This research may further elucidate genetic susceptibility to multisystem viral infections and establish genetic markers for severe clinical outcome.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Giatraki, Viktoria
  • Γιατράκη, Βικτωρία

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62890

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Giatraki, Viktoria; Γιατράκη, Βικτωρία. Βιταμίνη D και ευπάθεια στη νόσο COVID – 19 σε παιδιά. University of Crete (UOC), 2026. http://hdl.handle.net/10442/hedi/62890